Literature DB >> 16218783

Adeno-associated virus inverted terminal repeats improve neuronal transgene expression mediated by baculoviral vectors in rat brain.

Chao-Yang Wang1, Shu Wang.   

Abstract

Baculoviral vectors can transduce neurons in the CNS but mediate only transient expression of transgenes. We have developed a new baculoviral vector in which the inverted terminal repeats (ITRs) of adeno-associated virus are used to flank a luciferase reporter gene cassette harboring a neuron-specific promoter. When tested in rat brain, the new viral vector was able to provide transgene expression for at least 90 days. Immunohistological analysis demonstrated that ITR flanking did not affect the cellular preference of the neuronal promoter in the context of baculovirus. These findings establish an effective way to engineer baculoviral vectors in order to achieve sustained expression of a functional gene for gene therapy for neurodegenerative disorders and physiological studies of neurons.

Entities:  

Mesh:

Year:  2005        PMID: 16218783     DOI: 10.1089/hum.2005.16.1219

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  11 in total

1.  A pH-sensitive heparin-binding sequence from Baculovirus gp64 protein is important for binding to mammalian cells but not to Sf9 insect cells.

Authors:  Chunxiao Wu; Shu Wang
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Hybrid baculovirus-adeno-associated virus vectors for prolonged transgene expression in human neural cells.

Authors:  Chaoyang Wang
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

Review 3.  Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics.

Authors:  Ryan G Soderquist; Melissa J Mahoney
Journal:  Expert Opin Drug Deliv       Date:  2010-03       Impact factor: 6.648

4.  Efficient gene delivery into cell lines and stem cells using baculovirus.

Authors:  Li-Yu Sung; Chiu-Ling Chen; Shih-Yeh Lin; Kuei-Chang Li; Chia-Lin Yeh; Guan-Yu Chen; Chin-Yu Lin; Yu-Chen Hu
Journal:  Nat Protoc       Date:  2014-07-10       Impact factor: 13.491

5.  Recombinant baculovirus as a highly potent vector for gene therapy of human colorectal carcinoma: molecular cloning, expression, and in vitro characterization.

Authors:  Arghya Paul; Barbara A Jardin; Arun Kulamarva; Meenakshi Malhotra; Cynthia B Elias; Satya Prakash
Journal:  Mol Biotechnol       Date:  2010-06       Impact factor: 2.695

6.  Evaluation of cre recombinase delivery in mammalian cells using baculovirus infection.

Authors:  Eric Erbs; Amynah A Pradhan; Audrey Matifas; Brigitte L Kieffer; Dominique Massotte
Journal:  J Biotechnol       Date:  2013-05-31       Impact factor: 3.307

7.  Development of a hybrid baculoviral vector for sustained transgene expression.

Authors:  Wen-Hsin Lo; Shiaw-Min Hwang; Ching-Kuang Chuang; Chi-Yuan Chen; Yu-Chen Hu
Journal:  Mol Ther       Date:  2009-02-24       Impact factor: 11.454

Review 8.  Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.

Authors:  Julia Fakhiri; Dirk Grimm
Journal:  Mol Ther       Date:  2021-04-05       Impact factor: 11.454

Review 9.  Baculovirus-mediated gene delivery and RNAi applications.

Authors:  Kaisa-Emilia Makkonen; Kari Airenne; Seppo Ylä-Herttulala
Journal:  Viruses       Date:  2015-04-22       Impact factor: 5.048

10.  Enhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: a comparative study.

Authors:  Li-Yu Sung; Chiu-Ling Chen; Shih-Yeh Lin; Shiaw-Min Hwang; Chia-Hsin Lu; Kuei-Chang Li; Alice S Lan; Yu-Chen Hu
Journal:  Nucleic Acids Res       Date:  2013-05-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.